Advice on military veterans with concerns over Mefloquine

Individuals who may have taken Mefloquine prescribed by the Ministry of Defence (MoD) are now being offered support from the MoD’s Single Point of Contact (SPOC) for Mefloquine, launched on 5 September 2016. This signposts veterans to appropriate advice through existing resources and patient pathways.  A summary of the signposting algorithm is attached, which provides advice to individuals seeking information, those with health concerns, those who wish to make a complaint or those pursuing a legal claim.

Veterans will be encouraged to register their status with their NHS GP (Read Code XaX3) should they not previously have done so, to enable a pathway to existing resources in the NHS should they have concerns about their health.  If a veteran attends your practice with a history that they have (or may have) used Mefloquine in the past, this letter serves 3 uses: 

  1. Information for you on what advice your patient has already been given.
  2. Information on how to obtain copies of their military medical records should your records not hold a sufficient summary to assess the patient’s concerns.
  3. Some guidance on what options may be available to you in addition to your routine management. 

The information that your patient has been given is included in the leaflet attached and includes the contact details for obtaining a copy of their military medical records.  Since much of the focus has been the on mental health issues surrounding the use of Mefloquine, a link is provided to the Veterans and Reservists Mental Health Programme (VRMHP).  If your records confirm that your patient took Mefloquine while in the military (or you have reason to believe this is the case) and they have mental health issues that you would wish to refer for further assessment or treatment, the VRMHP can provide an assessment and , if appropriate, enable further follow-up and treatment through local NHS resources. 

You may find that you can provide information, reassurance or treatment within your routine patient pathways and may choose to support the veteran locally.  Further information and education on veterans’ health is available on the free to access e-Learning for Health.

Last updated : 22 Sep 2016

 

Mword 31 - We have your backs (01 Dec 2016)

1 December...
Read more »

Meeting with David Burrowes MP (24 Nov 2016)

On 4 November Dr Michelle Drage met David Burrowes, the Conservative MP for Enfield Southgate, at the Gillan House Surgery in his constituency. They were joined by Dr Vicky Weeks,...
Read more »

Health Select Committee winter pressure report endorses community general practice model (24 Nov 2016)

On 3 November the Health Select Committee released its report Winter pressure in accident and emergency departments. The main findings reflect our concerns that lack of support for community...
Read more »

PCSE Performers List problems and alternative arrangements (24 Nov 2016)

All GP trainees, newly qualified GPs and GPs applying to join the Medical Performers’ List should be aware of the following issues: GPs are not lawfully allowed to perform any...
Read more »

New GPC Co-Commissioning Guidance (24 Nov 2016)

The BMA General Practitioners Committee have issued a guidance update for GP practices and LMCs in England about options for Clinical Commissioning Groups (CCGs) to take greater commissioning control (“co-commissioning”),...
Read more »

2016 Autumn Statement and Dr Michelle Drage's response (24 Nov 2016)

Yesterday (Wednesday) Chancellor, Rt Hon Philip Hammond MP, delivered his first, and last, Autumn Statement. From 2017 there will be a Spring statement responding the Spring OBR report and an...
Read more »

Our November 2016 workforce survey is now live (24 Nov 2016)

Thank you in advance for making space in your hectic day to complete our short survey on practice workforce issues which will help us to gather insight to share with...
Read more »

Patient participation workshops starting in the New Year (24 Nov 2016)

Our Patient Engagement project has been working with practices and patient participation group (PPG) members to identify the benefits and challenges involved in developing active and effective PPGs. As a...
Read more »
Next Page »
« Previous Page